These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21336425)

  • 21. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
    Wen H; Wang HJ; Dong B; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
    Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease.
    Leclercq I
    Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H; Camilo ME
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents.
    Arslan N; Tokgoz Y; Kume T; Bulbul M; Sayın O; Harmancı D; Akdogan GG
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1141-7. PubMed ID: 23740679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
    Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P
    Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease in children.
    Mager DR; Roberts EA
    Clin Liver Dis; 2006 Feb; 10(1):109-31, vi-vii. PubMed ID: 16376797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
    J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver.
    Hirsch S; Poniachick J; Avendaño M; Csendes A; Burdiles P; Smok G; Diaz JC; de la Maza MP
    Nutrition; 2005 Feb; 21(2):137-41. PubMed ID: 15723740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GI epidemiology: nonalcoholic fatty liver disease.
    Angulo P
    Aliment Pharmacol Ther; 2007 Apr; 25(8):883-9. PubMed ID: 17402991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.